Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study

Lupus. 2023 Nov;32(13):1486-1492. doi: 10.1177/09612033231208347. Epub 2023 Oct 18.

Abstract

Objective: To compare clinical and laboratory data obtained from patients with primary Antiphospholipid Syndrome (PAPS) with and without limb ischemia (LI).

Methods: A transverse study with 66 (83.3% female) PAPS patients was performed. All data were evaluated. Patients were subdivided into one of two groups: PAPS with LI and PAPS without LI and compared.

Results: Sixty-six primary APS were selected. PAPS with LI group exhibited a longer disease duration (p = .012) and more arterial events (p = .002). A lower frequency of venous events was observed in PAPS with LI (p = .007), and deep venous thrombosis (p = .016). Furthermore, PAPS with LI patients had more deficiency of protein C of coagulation (p = .015) than the others.

Conclusion: PAPS and LI have a distinct clinical and laboratory spectra from those without LI and it is characterized by an increased frequency of protein C deficiency, and a lower frequency of venous events, deep venous thrombosis and IgM anticardiolipin.

Keywords: Antiphospholipid syndrome; antiphospholipid antibodies; arterial thrombosis; ischemic limb; thrombosis.

Publication types

  • Observational Study

MeSH terms

  • Antiphospholipid Syndrome* / complications
  • Female
  • Humans
  • Ischemia / etiology
  • Lupus Erythematosus, Systemic*
  • Male
  • Retrospective Studies
  • Venous Thrombosis* / epidemiology
  • Venous Thrombosis* / etiology